| Literature DB >> 26166314 |
Suzanne Aura Victoria van Asten1, Edgar Joseph Geradus Peters, Yin Xi, Lawrence Alfred Lavery.
Abstract
PURPOSE: To systematically review the value of serum inflammatory markers to diagnose diabetic foot osteomyelitis (DFO). STUDY SELECTION: Studies to diagnose DFO using biomarkers erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin (PCT), interleukins (IL-2, IL-6, IL-8) and tumor necrosis factor alfa (TNF.) were retrieved from EMBASE and PubMed with no language restrictions through July 2014. DATA EXTRACTION: We summarized clinical characteristics of the studies and used bivariate random effects models and summary receiver operating characteristic curves to estimate sensitivity and specificity for each marker. DATA SYNTHESIS: A total of 8 qualifying studies were included in our meta-analysis. Bivariate pooled sensitivity and specificity of the 6 studies examining ESR were 0.81 (95% CI 0.71-0.88) and 0.90 (95% CI 0.75-0.96) respectively. Due to the paucity of data, models did not converge for the other biomarkers.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26166314 DOI： 10.2174/1573399811666150713104401
Source DB: PubMed Journal: Curr Diabetes Rev ISSN： 1573-3998